⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNOA News
Sonoma Pharmaceuticals, Inc. Common Stock
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
accessnewswire.com
SNOA
Form 8-K
sec.gov
SNOA
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
accessnewswire.com
SNOA
Form 8-K
sec.gov
SNOA
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
accessnewswire.com
SNOA
Form 8-K
sec.gov
SNOA
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
accessnewswire.com
SNOA
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
accessnewswire.com
SNOA